Patrik Verstreken,Vanessa Morais Epifânio,Melissa Vos
申请号：
US15525566
公开号：
US20170319610A1
申请日:
2015.11.20
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This application relates to the field of neurodegenerative diseases, more particularly to the field of Parkinson's disease. In particular, the disclosure describes that inhibitors reducing FAS activity can be used for treatment of Parkinson's disease, in particular, the treatment of patients suffering from Parkinson's disease having loss of function mutations in PINK1 or PARKIN genes.
